Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73.8M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
9.53M
-
Shares change
-
+320K
-
Total reported value, excl. options
-
$335M
-
Value change
-
+$11.9M
-
Put/Call ratio
-
0.07
-
Number of buys
-
27
-
Number of sells
-
-34
-
Price
-
$35.21
Significant Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q1 2021
99 filings reported holding RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share as of Q1 2021.
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.53M shares
of 73.8M outstanding shares and own 12.9% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.53M shares), Avoro Capital Advisors LLC (1.53M shares), BlackRock Inc. (1.49M shares), VR Adviser, LLC (853K shares), VANGUARD GROUP INC (693K shares), PARSONS CAPITAL MANAGEMENT INC/RI (451K shares), STATE STREET CORP (291K shares), Ikarian Capital, LLC (290K shares), GEODE CAPITAL MANAGEMENT, LLC (239K shares), and FRANKLIN RESOURCES INC (225K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.